Amarin Corp Plc (AMRN)

[couldbebetter]

No doubt EPA at the right dose does many good things...and at some point supply may be constrained. Big Pharma may figure what the best use of the limited supply is. Of course you cannot supply enough EPA to treat 70 million people...if you only have enough to treat say 3 million people then you will probably treat those who re at the highest risk for cardiovascular events. The point of my post is that BP will see AMRN and its patent portfolio as worthy of a substantial takeover offer once Reduce-It results are out. The price they pay will be in direct correlation to the benefit derived. I am hopeful of a 15-25% net benefit which should make a takeover bid of $5-10 billion doable. I can also envision a consortium of BP who will share marketting costs and each BP will use their distribution network to service the market allowing for much greater market penetration. For example having Pfizer and Astra-Zenica jointly own AMRN or at least a sales agreement.